303 related articles for article (PubMed ID: 36803263)
1. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
[TBL] [Abstract][Full Text] [Related]
2. Comparison between screening for primary aldosteronism with and without drug adjustment.
Hua Y; He Q
Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
[TBL] [Abstract][Full Text] [Related]
3. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
Tezuka Y; Turcu AF
Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
[TBL] [Abstract][Full Text] [Related]
5. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
[TBL] [Abstract][Full Text] [Related]
6. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
[TBL] [Abstract][Full Text] [Related]
7. Primary aldosteronism in a general population sample. The Czech post-MONICA study.
Widimský J; Bruthans J; Wohlfahrt P; Krajčoviechová A; Šulc P; Linhart A; Filipovský J; Lánská V; Cífkova R
Blood Press; 2020 Jun; 29(3):191-198. PubMed ID: 32036692
[No Abstract] [Full Text] [Related]
8. What We Know about and What Is New in Primary Aldosteronism.
Ekman N; Grossman AB; Dworakowska D
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255973
[TBL] [Abstract][Full Text] [Related]
9. Screening for primary aldosteronism in a primary care unit.
Volpe C; Wahrenberg H; Hamberger B; Thorén M
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):212-9. PubMed ID: 23118039
[TBL] [Abstract][Full Text] [Related]
10. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
Nanba AT; Wannachalee T; Shields JJ; Byrd JB; Rainey WE; Auchus RJ; Turcu AF
J Clin Endocrinol Metab; 2019 Feb; 104(2):487-492. PubMed ID: 30239792
[TBL] [Abstract][Full Text] [Related]
11. A case of primary aldosteronism with a negative aldosterone-to-renin ratio.
Liu F; Wang L; Ding Y
BMC Cardiovasc Disord; 2021 Jul; 21(1):350. PubMed ID: 34294029
[TBL] [Abstract][Full Text] [Related]
12. Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension.
Bioletto F; Lopez C; Bollati M; Arata S; Procopio M; Ponzetto F; Beccuti G; Mengozzi G; Ghigo E; Maccario M; Parasiliti-Caprino M
Front Endocrinol (Lausanne); 2023; 14():1145186. PubMed ID: 37223051
[TBL] [Abstract][Full Text] [Related]
13. [Primary aldosteronism].
Fardella CE; Mosso LM; Carvajal CA
Rev Med Chil; 2008 Jul; 136(7):905-14. PubMed ID: 18949169
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism.
Yeung A; Friedmann P; In H; Bloomgarden N; McAuliffe JC; Libutti SK; Laird AM
J Surg Res; 2020 Dec; 256():673-679. PubMed ID: 32827833
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
[TBL] [Abstract][Full Text] [Related]
16. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
17. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
[TBL] [Abstract][Full Text] [Related]
18. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
19. Renal Artery Stenosis Complicated with Primary Aldosteronism.
Bao M; Li J
Int Heart J; 2023; 64(2):321-325. PubMed ID: 37005324
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of primary aldosteronism in primary care: a cross-sectional study.
Käyser SC; Deinum J; de Grauw WJ; Schalk BW; Bor HJ; Lenders JW; Schermer TR; Biermans MC
Br J Gen Pract; 2018 Feb; 68(667):e114-e122. PubMed ID: 29335324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
